UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000034812
Receipt No. R000039615
Scientific Title Study on improvement of sleeping disorder by ingestion of mixed fermented tea leaf powder made from unripe orange fruits and green tea leaves(2)
Date of disclosure of the study information 2018/11/22
Last modified on 2019/03/14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study on improvement of sleeping disorder by ingestion of mixed fermented tea leaf powder made from unripe orange fruits and green tea leaves(2)
Acronym Study on improvement of sleeping disorder by ingestion of mixed fermented tea leaf powder(2)
Scientific Title Study on improvement of sleeping disorder by ingestion of mixed fermented tea leaf powder made from unripe orange fruits and green tea leaves(2)
Scientific Title:Acronym Study on improvement of sleeping disorder by ingestion of mixed fermented tea leaf powder(2)
Region
Japan

Condition
Condition sleeping disorder
Classification by specialty
Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effects of ingention fermented tea leaf powder on the improvement of sleeping disorder.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes sleeping disorder
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 The subjects ingested the placebo meal for two weeks,and ingented the active meal for two weeks after two weeks.
Interventions/Control_2 The subjects ingested the active meal for two weeks,and ingented the active meal for two weeks after two weeks.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
70 years-old >
Gender Male and Female
Key inclusion criteria 1) Aged more than 20 (Healthy male and female between 20 and 70 years old)
2) Individuals who has subjective symptoms of sleeping disorder
3) Individuals who can refrain from over drinking and over eating during the test period
4) Individuals who understand the purpose and contents of the experiment
Key exclusion criteria 1)Subjects who are contracting or treating severe kidney and/or liver diseases
2)Individuals who have a chronic diseases and regularly use drugs
3)Those who can not stop taking a large amount of green tea or black tea during the test period
4)Pregnant women, or women with intending to become pregnant, and lactating woman
5)Individuals participating or intending to participate in a drug administration test
6)Individuals judged by the doctor to be unsuitable
Target sample size 30

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Kazunari Tanaka
Organization Univercity of Nagasaki
Division name Faculty of Nursing and Nutrition
Zip code
Address 1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195
TEL 0958135216
Email katanaka@sun.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Hideki Ito
Organization Univercity of Nagasaki
Division name Regional Partnership Center
Zip code
Address 1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195
TEL 0958135500
Homepage URL
Email katanaka@sun.ac.jp

Sponsor
Institute Univercity of Nagasaki
Institute
Department

Funding Source
Organization Bio-oriented Technology Research Advancement Institution,NARO
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 11 Month 22 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2018 Year 11 Month 17 Day
Date of IRB
2018 Year 10 Month 30 Day
Anticipated trial start date
2018 Year 11 Month 17 Day
Last follow-up date
2019 Year 01 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2018 Year 11 Month 08 Day
Last modified on
2019 Year 03 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039615

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.